April 30, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it has completed the topline analysis for the Phase 1 clinical trial evaluating Vaxart’s oral pill bivalent ...
This page requires JavaScript to be enabled to properly display data shown within components like charts, tables, etc.. Circulation of respiratory viruses is normally ...
Following a meeting of an advisory panel this week, the World Health Organization (WHO) recommended drugmakers to update their COVID-19 vaccine formulations to reflect the currently dominant SARS ...
Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought ... continue to enjoy access to Pfizer and BioNTech’s shots, the spokesperson added. Pfizer, for its part, remains ...
The world's first personalised mRNA jab for melanoma is being trialled on British patients in what has been hailed a potential 'gamechanger' for cancer treatment. The vaccine is custom-built for ...
Dairy cows on an Illinois cattle farm April 9. (Jim Vondruska/Reuters) Federal agencies with competing interests are slowing the country’s ability to track and control an outbreak of highly ...
After reviewing all available studies related to 19 potential harms of the COVID-19 vaccines, researchers found only one adverse event with a proven link to the Pfizer and Moderna shots ...
After reviewing all available studies related to 19 potential harms of the COVID-19 vaccines, researchers found only one adverse event with a proven link to the Pfizer and Moderna shots ...
A major bivalent COVID-19 vaccine induces production of neutralizing ... and its subvariants than in volunteers given only four shots of a monovalent vaccine. However, its main focus was still ...
A major bivalent COVID-19 vaccine induces production of neutralizing ... and its subvariants than in volunteers given only four shots of a monovalent vaccine. However, its main focus was still ...
Residents in Singapore are split on the need to get Covid-19 booster shots, a recent survey has revealed. And more people, especially those older than 60, now see the virus as a low health risk.